{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:09:58Z","timestamp":1779361798615,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,21]]},"DOI":"10.7759\/cureus.109341","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:02:11Z","timestamp":1779361331000},"source":"Crossref","is-referenced-by-count":0,"title":["Chronic Myeloid Leukemia Masked by Massive Splenomegaly: Splenectomy as a Strategy in a Resource-Limited Setting"],"prefix":"10.7759","author":[{"given":"Sela","family":"Bun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia--advances in biology and new approaches to treatment","volume":"349","author":"Goldman JM","year":"2003","unstructured":"Goldman JM, Melo JV. Chronic myeloid leukemia--advances in biology and new approaches to treatment. N Engl J Med. 2003, 349:1451-64. 10.1056\/NEJMra020777","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx219","article-title":"Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Hochhaus A","year":"2017","unstructured":"Hochhaus A, Saussele S, Rosti G, et al.. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017, 28:iv41-51. 10.1093\/annonc\/mdx219","journal-title":"Ann Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01204-6","article-title":"Chronic myeloid leukaemia","volume":"398","author":"Cortes J","year":"2021","unstructured":"Cortes J, Pavlovsky C, Sau\u00dfele S. Chronic myeloid leukaemia. Lancet. 2021, 398:1914-26. 10.1016\/S0140-6736(21)01204-6","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.794269","article-title":"Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation","volume":"55","author":"Santos FP","year":"2014","unstructured":"Santos FP, Tam CS, Kantarjian H, Cortes J, Thomas D, Pollock R, Verstovsek S. Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation. Leuk Lymphoma. 2014, 55:121-7. 10.3109\/10428194.2013.794269","journal-title":"Leuk Lymphoma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1054\/blre.2000.0132","article-title":"Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia","volume":"14","author":"Mesa RA","year":"2000","unstructured":"Mesa RA, Elliott MA, Tefferi A. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia. Blood Rev. 2000, 14:121-9. 10.1054\/blre.2000.0132","journal-title":"Blood Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02664-w","article-title":"2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia","volume":"39","author":"Apperley JF","year":"2025","unstructured":"Apperley JF, Milojkovic D, Cross NC, et al.. 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Leukemia. 2025, 39:1797-813. 10.1038\/s41375-025-02664-w","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30458-6","article-title":"Access to pathology and laboratory medicine services: a crucial gap","volume":"391","author":"Wilson ML","year":"2018","unstructured":"Wilson ML, Fleming KA, Kuti MA, Looi LM, Lago N, Ru K. Access to pathology and laboratory medicine services: a crucial gap. Lancet. 2018, 391:1927-38. 10.1016\/S0140-6736(18)30458-6","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjaf485","article-title":"Surgical management of giant splenomegaly in chronic myeloid leukemia: a challenging splenectomy case","volume":"2025","author":"Alqatta W","year":"2025","unstructured":"Alqatta W. Surgical management of giant splenomegaly in chronic myeloid leukemia: a challenging splenectomy case. J Surg Case Rep. 2025, 2025:rjaf485. 10.1093\/jscr\/rjaf485","journal-title":"J Surg Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/488592-chronic-myeloid-leukemia-masked-by-massive-splenomegaly-splenectomy-as-a-strategy-in-a-resource-limited-setting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:02:11Z","timestamp":1779361331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/488592-chronic-myeloid-leukemia-masked-by-massive-splenomegaly-splenectomy-as-a-strategy-in-a-resource-limited-setting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.109341","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}